• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸MRI上的非高血供低强化结节:以扩散加权成像的作用为重点的肝细胞癌风险评估

Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.

作者信息

Briani Chiara, Di Pietropaolo Marco, Marignani Massimo, Carbonetti Francesco, Begini Paola, David Vincenzo, Iannicelli Elsa

机构信息

Radiology Unit, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.

Department of Digestive and Liver Disease, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.

出版信息

J Gastrointest Cancer. 2018 Sep;49(3):302-310. doi: 10.1007/s12029-017-9952-7.

DOI:10.1007/s12029-017-9952-7
PMID:28547117
Abstract

INTRODUCTION AND AIM

In cirrhotic patients, the characterization of hypovascular nodules, hypointense on hepatobiliary phase gadoxetic acid disodium-enhanced magnetic resonance images (Gd-EOB-DTPA-enhanced MRI), is essential to look for the proper approach strategy. Our objective was to evaluate the imaging features and risk assessment of hypovascular nodules, hypointense on Gd-EOB-DTPA-enhanced MRI, focusing on the diagnostic value of diffusion-weighted imaging (DWI).

MATERIAL AND METHODS

This prospective study includes 35 patients with 50 hypovascular hypointense nodules. Signal intensity on T2-weighted images and DWI, vascular pattern on dynamic contrast-enhanced MRI and on hepatobiliary phase, and volume doubling time were analyzed for each nodule as well as patient's clinical features. Univariate and multivariate analyses were made to determine the variables associated with the development of hypervascular pattern.

RESULTS

On 24 months follow-up period, 40% of the hypointense nodules (mean size 14 mm ± 6.1) became hypervascular hepatocellular carcinoma (HCC) with 6 and 12 months cumulative risk of 45 and 55%. Nine/12 (75%, mean size 15.50 mm ± 7.2) that appeared hyperintense in DWI at first exam show malignant transformation (p value = 0.007). Univariate and multivariate analyses identified hyperintensity at initial DWI (OR 6.49; 95% CI 1.28-32.80; p value = 0.009) and size ≥10 mm (OR 6.22; 95% CI 1.57-24.63; p value = 0.024) as independent factors with the development of HCC.

CONCLUSION

In conclusion, hypovascular lesions ≥10 mm and those hyperintense in DWI were associated with progression to hypervascular HCC. A close follow-up or histological characterization is recommended to improve patients outcome and to develop effective treatment.

摘要

引言与目的

在肝硬化患者中,对肝胆期钆塞酸二钠增强磁共振成像(Gd-EOB-DTPA增强MRI)上呈低强化的低血供结节进行特征描述,对于寻找合适的治疗策略至关重要。我们的目的是评估Gd-EOB-DTPA增强MRI上呈低强化的低血供结节的影像特征和风险评估,重点关注扩散加权成像(DWI)的诊断价值。

材料与方法

这项前瞻性研究纳入了35例患者的50个低血供低强化结节。分析了每个结节在T2加权图像和DWI上的信号强度、动态对比增强MRI及肝胆期的血管模式、体积倍增时间以及患者的临床特征。进行单因素和多因素分析以确定与高血供模式发展相关的变量。

结果

在24个月的随访期内,40%的低强化结节(平均大小14mm±6.1)发展为高血供肝细胞癌(HCC),6个月和12个月的累积风险分别为45%和55%。首次检查时在DWI上呈高信号的12个结节中有9个(75%,平均大小15.50mm±7.2)发生了恶性转化(p值=0.007)。单因素和多因素分析确定初始DWI上的高信号(OR 6.49;95%CI 1.28 - 32.80;p值=0.009)和大小≥10mm(OR 6.22;95%CI 1.57 - 24.63;p值=0.024)是与HCC发展相关的独立因素。

结论

总之,大小≥10mm的低血供病变以及DWI上呈高信号的病变与进展为高血供HCC相关。建议密切随访或进行组织学特征分析,以改善患者预后并制定有效的治疗方案。

相似文献

1
Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.钆塞酸MRI上的非高血供低强化结节:以扩散加权成像的作用为重点的肝细胞癌风险评估
J Gastrointest Cancer. 2018 Sep;49(3):302-310. doi: 10.1007/s12029-017-9952-7.
2
Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.慢性肝病患者钆塞酸二钠增强磁共振成像上肝胆期呈低血供低信号结节且T2WI无高信号:长期转归及向高血供转变的危险因素
Eur Radiol. 2016 Oct;26(10):3728-36. doi: 10.1007/s00330-015-4146-9. Epub 2015 Dec 15.
3
Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.钆塞酸二钠增强磁共振成像肝胆期上小于1厘米的低信号结节的影像学特征,这些结节在慢性肝病患者中进展为高血供肝细胞癌。
Acta Radiol. 2015 May;56(5):526-35. doi: 10.1177/0284185114534652. Epub 2014 May 16.
4
Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas.肝细胞期钆塞酸增强磁共振图像上的非富血供低信号结节:磁共振肝胆期低信号结节向富血供肝细胞癌的转化。
Gut Liver. 2018 Jan 15;12(1):79-85. doi: 10.5009/gnl17046.
5
Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.肝硬化患者肝胆期钆塞酸增强 MRI 上低血供低信号结节:弥散加权成像预测向富血供 HCC 进展的潜力。
Radiology. 2012 Oct;265(1):104-14. doi: 10.1148/radiol.12112649. Epub 2012 Aug 13.
6
Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules.扩散加权成像与钆塞酸增强磁共振成像在肝细胞癌及乏血供肝细胞结节评估中的比较
Clin Imaging. 2015 May-Jun;39(3):468-75. doi: 10.1016/j.clinimag.2014.12.020. Epub 2015 Jan 7.
7
Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.钆塞酸增强磁共振成像及扩散加权成像在酒精性肝硬化患者中鉴别高血供增生结节与小(<3 cm)高血供肝细胞癌的价值:一项回顾性病例对照研究
J Magn Reson Imaging. 2020 Jan;51(1):70-80. doi: 10.1002/jmri.26768. Epub 2019 May 6.
8
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.钆塞酸 MRI 和扩散加权成像在诊断肝细胞癌早期复发中的性能。
Eur Radiol. 2020 Jan;30(1):186-194. doi: 10.1007/s00330-019-06351-0. Epub 2019 Aug 1.
9
Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.慢性肝病患者中,钆塞酸增强肝胆期呈高信号的乏血供肝结节内富血供肝癌进展的发生率。
Jpn J Radiol. 2014 Jul;32(7):405-13. doi: 10.1007/s11604-014-0323-z. Epub 2014 May 24.
10
Hypervascular Transformation of Hypovascular Hypointense Nodules in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: A Systematic Review and Meta-Analysis.钆塞酸增强 MRI 肝胆期低灌注低信号结节的富血管化转变:系统评价和荟萃分析。
AJR Am J Roentgenol. 2017 Oct;209(4):781-789. doi: 10.2214/AJR.16.17711. Epub 2017 Jul 25.

引用本文的文献

1
The value of Gd-EOB-DTPA-enhanced MRI in the differential diagnosis of HCC with hyperintensity on HBP and FNH.钆塞酸二钠增强磁共振成像在肝细胞癌与肝胆期高信号的局灶性结节性增生鉴别诊断中的价值
Medicine (Baltimore). 2025 Jun 27;104(26):e43106. doi: 10.1097/MD.0000000000043106.
2
Hepatobiliary-Phase Hypointense Nodules Without Arterial-Phase Hyperenhancement: Developing a Risk Stratification for Hypervascular Transformation Based on a Real-World Observational Cohort Study.肝胆期低信号结节且无动脉期强化:基于真实世界观察性队列研究制定高血管转化风险分层。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241299003. doi: 10.1177/15330338241299003.
3

本文引用的文献

1
New Approaches in Locoregional Therapies for Hepatocellular Carcinoma.肝细胞癌局部区域治疗的新方法
J Gastrointest Cancer. 2016 Sep;47(3):239-46. doi: 10.1007/s12029-016-9840-6.
2
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.《日本肝癌研究组基于JSH共识的肝细胞癌管理临床实践指南:2014年更新》
Liver Cancer. 2014 Oct;3(3-4):458-68. doi: 10.1159/000343875.
3
Pathology-MRI Correlation of Hepatocarcinogenesis: Recent Update.
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
肝细胞癌管理共识指南:台湾肝癌协会和台湾胃肠病学会2023年关于监测、诊断、全身治疗及治疗后监测的更新
Liver Cancer. 2024 Feb 12;13(5):468-486. doi: 10.1159/000537686. eCollection 2024 Oct.
4
Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement.肝硬化患者中具有转化为肝细胞癌风险的肝脏病变:肝胆期低强化结节且动脉期无强化。
J Clin Transl Hepatol. 2024 Jan 28;12(1):100-112. doi: 10.14218/JCTH.2023.00130. Epub 2023 Nov 29.
5
Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma.最近在非侵入性磁共振成像评估肝细胞癌方面的进展。
World J Gastroenterol. 2018 Jun 21;24(23):2413-2426. doi: 10.3748/wjg.v24.i23.2413.
肝癌发生的病理学与磁共振成像相关性:最新进展
J Pathol Transl Med. 2015 May;49(3):218-29. doi: 10.4132/jptm.2015.04.15. Epub 2015 May 15.
4
Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.钆塞酸二钠增强磁共振成像对巨大炎症性肝细胞腺瘤的诊断价值:1例报告并文献复习
J Gastrointest Cancer. 2015 Dec;46(4):421-5. doi: 10.1007/s12029-015-9715-2.
5
Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.钆塞酸增强 MRI 肝胆期非高血供低信号结节:射频消融后 HCC 复发的风险。
J Hepatol. 2015 May;62(5):1122-30. doi: 10.1016/j.jhep.2014.12.015. Epub 2014 Dec 18.
6
Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.钆塞酸二钠增强磁共振成像肝胆期上小于1厘米的低信号结节的影像学特征,这些结节在慢性肝病患者中进展为高血供肝细胞癌。
Acta Radiol. 2015 May;56(5):526-35. doi: 10.1177/0284185114534652. Epub 2014 May 16.
7
Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection.术前钆塞酸二钠增强磁共振成像及早期肝细胞癌的同步治疗可延长肝切除术后进展期肝细胞癌患者的无复发生存期。
HPB Surg. 2014;2014:641685. doi: 10.1155/2014/641685. Epub 2014 Feb 19.
8
Recent advances in estimating hepatic functional reserve in patients with chronic liver damage.慢性肝损伤患者肝功能性储备评估的最新进展
Hepatol Res. 2015 Jan;45(1):10-9. doi: 10.1111/hepr.12325. Epub 2014 Apr 24.
9
Factors affecting screening for hepatocellular carcinoma.影响肝细胞癌筛查的因素。
Ann Hepatol. 2014 Mar-Apr;13(2):204-10.
10
Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging.使用钆塞酸二钠增强肝细胞期磁共振成像进行肝细胞癌风险评估
Hepatol Res. 2014 Dec;44(13):1339-46. doi: 10.1111/hepr.12309. Epub 2014 Apr 24.